Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Asri Karya Lestari Tbk. (ASLI) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Asri Karya Lestari Tbk.
UBC Medical Indonesia Tbk.

Price performance

Price movement over the last 24 hours

Key statistics

Asri Karya Lestari Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Asri Karya Lestari Tbk. trades at Rp200 (market cap 1.29T, 1.73M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp152 (market cap 556.95B, 60.83M 24h volume). The key difference: Asri Karya Lestari Tbk. is far larger — about 2.3× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (60.83M versus 1.73M). Which is the better fit depends on your goals.

ASLILABS
Market Cap
1.29T556.95B
Volume
1.73M60.83M
Lot
17.29K608.34K
Turnover
349.74M10.26B
Average Price
202.26168.64
Value
349.74M10.26B
Indicative Equilibrium Price
200152
Indicative Equilibrium Volume
1.01K4.52K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ASLI
View details
LABS
View details

About Asri Karya Lestari Tbk.

PT Asri Karya Lestari Tbk (‘the Entity’) was established as a limited liability company based on deed No. 05 on December 20, 2008 before Notary Syanti Hardiyanti, SH in Jakarta. The entity started its commercial operations in 2009

Read more on ASLI

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS